Merit Medical Systems (MMSI) Capital Expenditures (2010 - 2026)

Merit Medical Systems has disclosed Capital Expenditures across 17 years of filings, most recently posting $16.0 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $16.0 million, up 319.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.3 million (down 92.73% YoY), and the FY2025 annual result was $3.1 million, down 91.08% from the prior year.
• Capital Expenditures came in at $16.0 million for Q1 2026 at Merit Medical Systems, up from -$1.9 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $210.0 million in Q4 2024 to a low of -$29.8 million in Q3 2025.
• The 5-year median for Capital Expenditures is $3.5 million (2024), against an average of $14.7 million.
• Peak annual rise in Capital Expenditures reached 5647.13% in 2024, while the deepest fall reached 990.77% in 2024.
• Merit Medical Systems' Capital Expenditures stood at -$28.8 million in 2022, then soared by 112.67% to $3.7 million in 2023, then surged by 5647.13% to $210.0 million in 2024, then tumbled by 100.9% to -$1.9 million in 2025, then surged by 948.83% to $16.0 million in 2026.
• The last three Capital Expenditures figures came in at $16.0 million (Q1 2026), -$1.9 million (Q4 2025), and -$29.8 million (Q3 2025), per Business Quant data.